Stocktoria
Zhongchao Inc. ZCMD
Zhongchao Inc. (ZCMD) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $11.4M at a -55.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -4.13 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.639 |
| Retained earnings / assets | -0.588 |
| EBIT / assets | -0.256 |
| Equity / liabilities | 14.59 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ZCMD | Zhongchao Inc. | 2/9 | 15.87 | — | -28.3% |
| EEIQ | EpicQuest Education Group International Ltd | 3/9 | -0.07 | — | — |
| ZNB | Zeta Network Group | 2/9 | — | — | — |
| YQ | 17 Education & Technology Group Inc. | 4/9 | — | — | -41.5% |
| WAFU | Wah Fu Education Group Ltd | 3/9 | 8.92 | — | — |
| GV | Visionary Holdings Inc. | 4/9 | -6.69 | — | — |
| JZ | Jianzhi Education Technology Group Co Ltd | 3/9 | -8.21 | — | -54.2% |
About Zhongchao Inc.
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
FAQ
Is ZCMD financially healthy?
Zhongchao Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does ZCMD pay a dividend?
No, Zhongchao Inc. does not currently pay a dividend.
How profitable is ZCMD?
In FY2025, Zhongchao Inc. had a net margin of -55.5% and a return on equity of -27.9%.
Is ZCMD a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Zhongchao Inc.: a Piotroski F-score of 2/9, an Altman Z″ in the safe zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.